| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 24, 2026 | ±4.5% | +1.8% | over-priced |
| October 24, 2025 | ±5.0% | -2.5% | over-priced |
| July 25, 2025 | ±3.7% | +0.1% | over-priced |
| April 25, 2025 | ±6.0% | -1.7% | over-priced |
| November 7, 2024 | ±2.8% | -3.1% | under-priced |
| July 29, 2024 | ±2.8% | -1.5% | over-priced |
| April 24, 2024 | ±3.0% | +0.3% | over-priced |
| October 25, 2023 | ±3.6% | +0.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.55 | $5.4B | $464M |
| Q4 FY2025 | — | $5.7B | $589M |
| Q3 FY2025 | $0.02 | $5.6B | $20M |
| Q2 FY2025 | $0.55 | $5.5B | $480M |
Halliburton Company (HAL) reports in 83 days, with the next report estimated for September 4, 2026. Across the last 8 reports, options priced an average ±3.9% earnings move while the stock actually moved 1.4% on average — the market has systematically over-priced HAL's earnings risk. Fundamentals into the print: EPS up 129.2% year-over-year, revenue down 0.3%. QuantLogix's live 5-factor engine currently reads HAL as a buy at 53/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →